- 同
- s
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 制吐剤の特性 characteristics of antiemetic drugs
- 2. 薬物アレルギー患者へのアプローチ an approach to the patient with drug allergy
- 3. リウマチ性疾患における免疫抑制剤および疾患修飾剤の使用の概要 overview of the use of immunosuppressive and disease modifying drugs in the rheumatic diseases
- 4. 化学療法誘発性悪心および嘔吐の予防および治療 prevention and treatment of chemotherapy induced nausea and vomiting
- 5. 血管新生阻害剤の概要 overview of angiogenesis inhibitors
English Journal
- Generation and characterization of quinolone-specific DNA aptamers suitable for water monitoring.
- Reinemann C1, Freiin von Fritsch U2, Rudolph S2, Strehlitz B2.
- Biosensors & bioelectronics.Biosens Bioelectron.2016 Mar 15;77:1039-47. doi: 10.1016/j.bios.2015.10.069. Epub 2015 Oct 28.
- Quinolones are antibiotics that are accredited in human and veterinary medicine but are regularly used in high quantities also in industrial livestock farming. Since these compounds are often only incompletely metabolized, significant amounts contaminate the aquatic environment and negatively impact
- PMID 26547431
- Local release of masitinib alters in vivo implantable continuous glucose sensor performance.
- Avula M1, Jones D2, Rao AN3, McClain D2, McGill LD4, Grainger DW5, Solzbacher F6.
- Biosensors & bioelectronics.Biosens Bioelectron.2016 Mar 15;77:149-56. doi: 10.1016/j.bios.2015.08.059. Epub 2015 Sep 14.
- Continuous glucose monitoring (CGM) sensors are often advocated as a clinical solution to improve long-term glycemic control in the context of diabetes. Subcutaneous sensor inflammatory response, fouling and fibrous encapsulation resulting from the host foreign body response (FBR) reduce sensor sens
- PMID 26402593
- Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia.
- Ciarcia R1, Damiano S1, Puzio MV1, Montagnaro S1, Pagnini F1, Pacilio C2, Caparrotti G3, Bellan C4, Garofano T5, Polito MS4, Giordano A4,5,6, Florio S1.
- Journal of cellular physiology.J Cell Physiol.2016 Mar;231(3):680-7. doi: 10.1002/jcp.25118. Epub 2015 Sep 1.
- To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often used second generation of tyrosine kinase inhibitors as Nilotinib (NIL); a such potent inhibitor of the BCR/ABL kinase and Dasatinib (DAS), a inhibitor of BCR/ABL kinase, and inhibitor SrC family kin
- PMID 26235483
Japanese Journal
- 生体内での薬物-受容体結合を基盤とした薬物動態と薬効の統合的解析
- YAKUGAKU ZASSHI 135(1), 137-150, 2015
- NAID 130004756472
- The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction : Bladder Selectivity Based on In Vivo Drug-Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder
- Journal of pharmacological sciences 112(2), 142-150, 2010-02-20
- NAID 10029888600
- The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug-Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder
- Journal of Pharmacological Sciences 112(2), 142-150, 2010
- NAID 130000160421
Related Links
- drug receptor any part of a cell, usually a large protein molecule, on the cell surface or in the cytoplasm with which a drug molecule interacts to trigger a response or effect. drug receptor A complex containing protein, located on a ...
- Define drug receptor. drug receptor synonyms, drug receptor pronunciation, drug receptor translation, English dictionary definition of drug receptor. n. 1. Physiology A specialized cell or group of nerve endings that responds to ? ...
Related Pictures
★リンクテーブル★
| 拡張検索 | 「drug-receptor complex」 |
| 関連記事 | 「drug」 |
「drug-receptor complex」
「drug」
- 同
- drugs